CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Sakurada Yoichi; Sugiyama Atsushi; Tanabe Naohiko; Kikushima Wataru; Kume Atsuki; Iijima Hiroyuki

首页> 外文期刊>Retina >CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

【24h】

CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

机译：脉络膜厚度作为光动力学治疗的预后因子与豚鼠脉络膜血管病变的AfliBercept或Ranibizumab

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To investigate factors associated with visual improvement and retreatment 12 months after a combination therapy of intravitreal injection of ranibizumab or aflibercept followed by photodynamic therapy for polypoidal choroidal vasculopathy.

机译：目的：在脊髓植物腔室玻璃体素瘤或AfliBercept的组合治疗后12个月后调查与视觉改善和后退的因素，然后进行息肉瘤脉络膜病变的光动力学治疗。

著录项

来源
《Retina》 |2017年第10期|共7页
作者
Sakurada Yoichi; Sugiyama Atsushi; Tanabe Naohiko; Kikushima Wataru; Kume Atsuki; Iijima Hiroyuki;
展开▼
作者单位

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

Univ Yamanashi Fac Med Dept Ophthalmol Yamanashi Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
choroidal thickness polypoidal choroidal vasculopathy; photodynamic therapy; aflibercept; ranibizumab;

机译：脉络膜厚斑瘤脉络膜病变;光动力疗法;AfliBibercept;Ranibizumab;

相似文献

外文文献
中文文献
专利

1. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY [J] . Sakurada Yoichi, Sugiyama Atsushi, Tanabe Naohiko, Retina . 2017,第10期

机译：脉络膜厚度作为光动力学治疗的预后因子与豚鼠脉络膜血管病变的AfliBercept或Ranibizumab
2. Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy [J] . MarukoI., IidaT., OyamadaH., American Journal of Ophthalmology: The International Journal of Ophthalmology . 2013,第3期

机译：玻璃体腔内雷珠单抗和光动力疗法治疗复发性息肉样脉络膜脉络膜血管病后的脉络膜厚度变化
3. Prognostic factors for combined ranibizumab and prompt verteporfin photodynamic therapy for polypoidal choroidal vasculopathy [J] . Hsia Yun, Chan Li-Wei, Yang Chang-Hao, Photodiagnosis and Photodynamic Therapy . 2019,第SEPa期

机译：雷珠单抗联合维替泊芬即时光动力疗法治疗息肉样脉络膜脉络膜血管病的预后因素
4. Prognostic Analysis of Polypoidal Choroidal Vasculopathy Using an Image-Based Approach [C] . Yong-Ming Chen, Wei-Yang Lin, Chia-Ling Tsai 2016 International Computer Symposium . 2016

机译：基于图像的方法对息肉样脉络膜血管病变的预后分析
5. Genetic Investigation of Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy. [D] . Liu, Ke. 2013

机译：年龄相关性黄斑变性和息肉样脉络膜血管病的遗传学研究。
6. One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy [O] . Marta Medina-Baena, María Jesús Huertos-Carrillo, Laura Rodríguez, 2018

机译：高加索雷珠单抗难治性多发性脉络膜脉络膜血管病高加索患者的阿非西普和光动力疗法的一年结果
7. Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy [O] . Kikushima Wataru, Atsushi Sugiyama, Seigo Yoneyama, 2020

机译：光学动力治疗的五年结果与脊髓瘤术或AFLIBERCEPT相结合的脊髓灰质脉络膜血管病变

CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

摘要

著录项

相似文献

相关主题

期刊订阅